BMY vs VBIX · P/E 17, rev $48.19B vs rev $26.9M
Bristol-Myers Squibb Company (BMY) versus Viewbix Inc. Common Stock (VBIX) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Viewbix Inc. Common Stock (VBIX) is a internet content & information company listed on NASDAQ.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported VBIX revenue for 2024-12-31 was $26.9M. Net income was -$14.1M. Revenue was down 66.2% from 2023-12-31 to 2024-12-31. VBIX currently screens at market cap $48.5M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. VBIX currently screens at market cap $48.5M.
Not investment advice. Open the BMY and VBIX stock pages for the full models.
Not investment advice.